Galia Luboshits
- Immunology top 5%
- T-cell and B-cell Immunology 4
- Immunotherapy and Immune Responses 3
- Immune Cell Function and Interaction 3
- Atherosclerosis and Cardiovascular Diseases 3
- Oncology top 5%
- Chemokine receptors and signaling 4
- Immunology and Allergy top 5%
-
- Cancer, Hypoxia, and Metabolism 2
- Rheumatology top 10%
-
- Angiogenesis and VEGF in Cancer 4
- Glycosylation and Glycoproteins Research 2
- Journals
- SHILAP Revista de lepidopterología (1 paper)European Heart Journal (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)
- Partner nations
- Israel
In The Last Decade
Galia Luboshits
15 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 85
- Immunology 877
- Oncology 506
- Immunology and Allergy 90
- Cancer Research 143
- Rheumatology 96
Countries citing papers authored by Galia Luboshits
This map shows the geographic impact of Galia Luboshits's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galia Luboshits with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galia Luboshits more than expected).
Fields of papers citing papers by Galia Luboshits
This network shows the impact of papers produced by Galia Luboshits. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galia Luboshits. The network helps show where Galia Luboshits may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Galia Luboshits, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2009 | 5 | |
| 3 | 2008 | 11 | |
| 4 | 2008 | 25 | |
| 5 | 2008 | 17 | |
| 6 | 2007 | 162 | |
| 7 | 2007 | 276 | |
| 8 | 2006 | 259 | |
| 9 | 2006 | 11 | |
| 10 | 2005 | 17 | |
| 11 | 2005 | 5 | |
| 12 | Breast carcinoma: a report on the potential usage of the CC chemokine RANTES as a marker for a progressive disease. | 2002 | 16 |
| 13 | The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. | 2002 | 268 |
| 14 | 2001 | 3 | |
| 15 | Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. | 1999 | 245 |
About Galia Luboshits
Galia Luboshits is a scholar working on Immunology, Immunology and Allergy and Cell Biology, having authored 15 papers that have together received 1.3k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (4 papers), T-cell and B-cell Immunology (4 papers), Chemokine receptors and signaling (4 papers), Immunotherapy and Immune Responses (3 papers), Immune Cell Function and Interaction (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Immunology (877 citations), Oncology (506 citations) and Immunology and Allergy (90 citations). Galia Luboshits has collaborated with scholars based in Israel. Frequent co-authors include Jacob George, David Planer, Gad Keren, Sima Shina, Adit Ben‐Baruch, Iafa Keydar, Adi Mor, G. Keren, Adam Mor and Arnon Afek. Their work appears in journals such as SHILAP Revista de lepidopterología, European Heart Journal and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.